NASDAQ : JANX

Janux Therapeutics, Inc.

$16.03 USD

$0.25 (1.58%)

Volume
829.62K
Average Volume
1.13M
Market Capitalization
$977.58M
P/E Ratio
-8.71
Dividend Yield
0.00%
Price Target
$22.00
Year High
$35.34
Year Low
$12.12
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$17.01

JANX Estimated and Actual Revenue by Quarter

JANX Estimated and Actual EPS by Quarter

JANX Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 4 -37.63M -14.51M -26.07M -37.63M -14.51M -26.07M
2028-09-30 4 -27.7M -10.69M -19.2M -27.7M -10.69M -19.2M
2028-06-30 5 -15.41M -5.94M -10.67M -15.41M -5.94M -10.67M
2028-03-31 2 -7.44M -2.87M -5.16M -7.44M -2.87M -5.16M
2027-12-31 3 -1.26M -487.52K -875.71K -1.26M -487.52K -875.71K
2027-09-30 3 -1.41M -543.2K -975.71K -1.41M -543.2K -975.71K
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 4 -54.49M -14.65M -34.57M 48.51M 125.77M 87.14M
2028-09-30 4 -54.01M -14.52M -34.27M 35.72M 92.6M 64.16M
2028-06-30 5 -60.72M -16.32M -38.52M 19.86M 51.5M 35.68M
2028-03-31 2 -65.72M -17.67M -41.69M 9.6M 24.88M 17.24M
2027-12-31 3 -77.76M -20.9M -49.33M 1.63M 4.22M 2.93M
2027-09-30 3 -68.24M -18.34M -43.29M 1.82M 4.71M 3.26M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 4 14.51M 37.63M 26.07M 5 -0.86947 -0.23373 -0.5516
2028-09-30 4 10.69M 27.7M 19.2M 10 -0.8619 -0.2317 -0.5468
2028-06-30 5 5.94M 15.41M 10.67M 7 -0.96893 -0.26047 -0.6147
2028-03-31 2 2.87M 7.44M 5.16M 5 -1.04869 -0.28191 -0.6653
2027-12-31 3 487.52K 1.26M 875.71K 4 -1.24092 -0.33358 -0.78725
2027-09-30 3 543.2K 1.41M 975.71K 8 -1.089 -0.29274 -0.69087